Skip to content
10-Q

Quarterly Report

PRINCIPIA BIOPHARMA INC.

0001564590-20-021981

← back to feed
Filed
May 6, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Apr 30, 2020 33.04M sh
Capex Q1 2020 · Mar 31, 2020 $178K
Capex Q1 2020 · Mar 31, 2019 $1.38M
Operating Cash Flow Q1 2020 · Mar 31, 2020 −$27.47M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$16.41M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $59.43M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $39.54M
Cash And Equivalents Q1 2020 · Mar 31, 2019 $14.67M
Cash And Equivalents Q1 2020 · Dec 31, 2018 $34.49M
Stockholders Equity Q1 2020 · Mar 31, 2020 $331.45M
Stockholders Equity Q1 2020 · Dec 31, 2019 $358.98M
Stockholders Equity Q1 2020 · Mar 31, 2019 $158.99M
Stockholders Equity Q1 2020 · Dec 31, 2018 $169.86M
Current Liabilities Q1 2020 · Mar 31, 2020 $18.02M
Current Liabilities Q1 2020 · Dec 31, 2019 $16.14M
Current Assets Q1 2020 · Mar 31, 2020 $316.1M
Current Assets Q1 2020 · Dec 31, 2019 $319.75M
Total Assets Q1 2020 · Mar 31, 2020 $362.78M
Total Assets Q1 2020 · Dec 31, 2019 $382.74M
Sga Expense Q1 2020 · Mar 31, 2020 $7.37M
Sga Expense Q1 2020 · Mar 31, 2019 $4.51M
Rd Expense Q1 2020 · Mar 31, 2020 $26.74M
Rd Expense Q1 2020 · Mar 31, 2019 $15.52M
Operating Income Q1 2020 · Mar 31, 2020 −$34.11M
Operating Income Q1 2020 · Mar 31, 2019 −$14.87M
Revenue Q1 2020 · Mar 31, 2020 $0
Revenue Q1 2020 · Mar 31, 2019 $5.16M